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The Massachusetts methodology for deriving allowable ambient limits, known as 
AALs, is summarized in a document developed by the Department of Environmental 
Protection (DEP) entitled the Chemical Health Effects Assessment Methodology 
(CHEM) and the Method to Derive Allowable Ambient Limits (AAL) or CHEM/AAL. 
The CHEM part of the document describes the methodology used to review the scientific 
data for four health endpoint categories for the chemical and assigns a score to each 
category. In the AAL section, information derived through CHEM is used to derive the 
Allowable Ambient Limit (AAL) for the chemical in air. AALs derived through the 
CHEM/AAL methodology are purely health-based numbers conservatively derived to be 
protective of public health. Thus far the DEP has developed AALs for 105 chemicals 
which were chosen, not on the basis of hazard, but to test the methodology on 
representative kinds of chemicals. 
 
The four health endpoint categories evaluated through CHEM are acute/chronic 
toxicity, carcinogenicity, mutagenicity and developmental/reproductive toxicity. 
 
Acute/Chronic Toxicity: 
 
The basis for assessing acute/chronic toxicity through CHEM/AAL is the 
occupational limit. Occupational limits from ACGIH, OSHA and NIOSH are reviewed 
along with the justification for each limit issued by the particular agency. Occupational 
limits from all three sources are reviewed because there are inconsistencies among these 
agencies as to procedures used to derive the occupational limits, (for example the criteria 
for identifying carcinogens is not consistent among the three agencies and sometimes 
even within the same agency.) 
 
The "Most Appropriate Occupational Limit" (MAOL) is then selected from those 
reviewed based on selection criteria identified in CHEM/AAL. Essentially the MAOL 
represents that occupational limit which comes closest to the Lowest Observed Adverse 
Effect Level (LOAEL) for effects cited by that occupational agency without exceeding it. 
Specific criteria considered in selecting the MAOL include the occupational limit's 
degree of protection, its relevance to documented health effects, the adequacy and 
comprehensiveness of the toxicity data cited, self-reported limitations in the occupational 
limit, severity of health effects accounted for, how recently the toxicological basis for the 
limit was reviewed and its relevance to long-term chronic effects. 
 
The chemical is then assigned a severity factor of from one to three points based 
on the severity of acute/chronic effects cited by the occupational sources. Severity of 
effect is used to account for the fact that effects occurring at the same level may not 
necessarily represent the same degree of hazard. In general, a lower severity factor is 
assigned to milder irritants, and chemicals producing transient, reversible effects while a 
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higher severity factor is assigned to chemicals producing irreversible effects, chronic 
effects or more widespread systemic effects involving multiple sites or organ systems. 
 
A final letter score from A to E is then assigned to the chemical for acute/chronic 
toxicity based on a scoring scheme considering MAOL and severity of effect. 
 
Carcinogenicity: 
 
The assessment of a chemical for carcinogenicity in CHEM/AAL involves a 
consideration of both qualitative information (in the form of weight of evidence) and 
quantitative dose-response information. 
 
Information on carcinogenicity from IARC, EPA-CAG, NTP and other sources is 
reviewed, along with primary sources when secondary sources are unavailable or when 
new data are published. A method analogous to the EPA method to assess weight-of-
evidence is then used to assign a weight-of-evidence category. 
 
Published cancer unit risk factors from EPA-CAG and others are then reviewed if 
available. If there has been no cancer unit risk published for a chemical or if the DEP 
does not agree with the EPA number, DEP will develop a cancer unit risk using the 
linearized multistage model if there are sufficient data. 
 
A final letter score from A to F or ND is then assigned to the chemical based on a 
scoring scheme which considers weight-of-evidence and carcinogenic unit risk. 
 
Mutagenicity: 
 
The main information source used in CHEM/AAL to assess mutagenicity is 
EPA's Genetic Toxicology Program database (GENE-TOX). GENE-TOX is a peer-
reviewed mutagenicity database which reports bioassay results for 73 mutagenic tests and 
is continuously updated. Mutagenicity information for a particular chemical is derived 
through GENE-TOX and is supplemented by information from IARC and primary 
scientific literature. 
 
A final letter score from A to E or ND is then assigned to the chemical using a 
scoring matrix developed for mutagenicity. This scoring matrix was derived by assigning 
relative weight to the various types of mutagenicity assays, (for example, human assays 
are assigned greater importance than animal assays; in vivo tests, more importance than 
in vitro tests, etc.) and to the number and variety of tests scoring positively for 
mutagenicity. 
 
Developmental/Reproductive: 
 
CHEM/AAL defines reproductive toxicity as "any effect resulting from parental 
exposure to a substance which interferes with conception, gestation, birth or development 
of offspring to healthy adult life." Developmental toxicity is defined in CHEM/AAL as 
including teratogenicity, embryotoxicity, fetotoxicity, perinatal or postnatal 
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developmental toxicity. 
 
The assessment of a chemical for developmental/reproductive effects in 
CHEM/AAL is based primarily on information derived from the primary science 
literature. Primary studies for both developmental and reproductive effects are reviewed 
and are critically evaluated (e.g. toxicologically, statistically, pharmacologically, etc.). 
 
Weight of evidence is determined for each endpoint using a scoring scheme 
similar to the scoring scheme used for carcinogenicity. 
 
A critical study is selected for developmental/reproductive toxicity. The Lowest 
Observed Effect Level (LOEL) is then identified from this study. A parameter developed 
by the DEP called the Risk Ratio is then determined. This is done by first selecting an 
LD50 from a toxicity study in which the species and exposure route are the same as in the 
study from which the LOEL is derived. The Risk Ratio is then calculated as LD50/LOEL 
and basically reflects the ratio of toxic doses of adult/fetus. 
 
A final letter score from A to E or ND for developmental toxicity is then assigned 
based on a scoring scheme which considers weight of evidence, LOEL and Risk Ratio. 
 
A critical study is also chosen for reproductive toxicity. Only the LOEL is 
identified from the study in this case and a final letter score from A to E or ND for 
reproductive toxicity is assigned based on a scoring scheme which considers weight-of-
evidence and LOEL. 
 
The lower of the developmental toxicity score and reproductive toxicity score is 
chosen as the final score for developmental/reproductive toxicity. 
 
AAL Derivation: 
 
The AAL is derived based on information derived in CHEM. At the end of this 
summary is a flowchart from CHEM/AAL outlining the steps used in deriving the final 
AAL. Briefly, the MAOL is adjusted for continuous exposure, adult/child differences, 
and high risk groups. At this point, another variable uncertainty factor of 10 called the 
TOX factor is applied on a case-by-case basis depending on whether it is felt that the 
toxicity data, as described by the occupational source, on which the selected MAOL is 
based, is adequate. The resulting value is now called the Adjusted MAOL.  
 
The methodology branches here to calculate both a Threshold Effects Exposure 
Limit (TEL) based on threshold effects (i.e., acute/chronic toxicity and 
developmental/reproductive toxicity) and a Nonthreshold Effects Exposure Limit (NTEL) 
based on nonthreshold effects (i.e., carcinogenicity and mutagenicity.) The TEL is 
derived by applying an uncertainty factor known as the Threshold Effects Uncertainty 
Factor (TEUF) of 1, 5 or 10 to the Adjusted MAOL which is mainly based on 
developmental/reproductive effects not accounted for in the MAOL. (CHEM/AAL 
specifies in this case: if the chemical is known to have developmental/reproductive 
effects, and this information was not considered in the occupational limit, then the TEUF 
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is 5 if the CHEM toxicity score is C or D; 10 if it is A or B.) Twenty percent of the TEL 
is then taken to represent that portion of a person's total exposure to this chemical which 
can result through air. If a cancer unit risk is available, the NTEL is derived using 
quantitative cancer risk assessment to calculate an excess lifetime cancer risk of 1 x 10-6. 
otherwise the NTEL is derived by applying an uncertainty factor known as the 
Nonthreshold Effects Uncertainty Factor (NTEUF) to the Adjusted MAOL, the 
magnitude of which is determined via a matrix which was developed to consider the 
scores for carcinogenicity and mutagenicity, as well as the structure-activity relationship 
(SAR) of the chemical (using a method which the Food and Drug Administration (FDA) 
uses to classify food additives, which essentially compares the structure of the chemical 
to the structure of other chemicals whose toxicity is better known.)  
 
The TEL is designated as a 24-hr. average concentration; the NTEL is assigned an 
annual average. The lower of the TEL and the NTEL is designated as the AAL.  
 
The AAL and TEL must be used together to be protective of public health for 
both threshold and nonthreshold effects.  
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ASSUMPTIONS USED IN DERIVATION OF FACTORS USED IN CHEM/AAL: 
 
1. 4.2 factor to adjust for continuous exposure: 
 
occupational exposure = 8 hrs x 5 days = 40 hrs 
  day  wk  wk 
 
continuous exposure = 24 hrs x 7 days = 168 hrs 
  day  wk  wk 
 
ratio determined = 168 hrs = 4.2 
  40 hrs 
 
 
2. 1.75 factor to adjust for adult to child differences: 
 
 
adult breathing rate: 
 
20 m3/ day 
child breathing rate: 
 
10 m3/day 
average adult weight: 
 
70 kg 
average child weight: 
 
20 kg 
ratio of child parameters 
 
over adult parameters: 
 
10 m3/day 
      20 kg       = 1.75 
20 m3/day 
70 kg 
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Figure III - 1. Derivation of AAL 
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Uncertainty Factor (TEUF) factor of 1, 5 or 10 to 
adjust for Effects Not Accounted for – (primarily 
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contribution (multi-media exposure adjustment) 
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Set NTEL to correspond to excess lifetime cancer 
risk of 1.00E-6 
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account for nonthreshold effects 
Quantitative cancer 
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the two as the AAL 
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CHEM/AAL - Attachment 1. 5/31/94 
 
Incorporation of Inhalation Reference Concentrations  
into the CHEM/AAL Process 
 
The Chemical Health Effects Assessment Methodology and the Method to Derive 
Allowable Ambient Limits (CHEM/AAL) (ORS, 1990) represents Massachusetts' current 
methodology to derive health-based exposure limits for chemical compounds in ambient 
air. At the time this methodology was developed, there was no consistently derived set of 
toxicity criteria available for inhalation exposures such as there was in the form of the 
Environmental Protection Agency (EPA) Reference Doses (RfDs) for ingestion 
exposures. The occupational literature was the only relatively consistent source of 
inhalation information available and was thus used as the starting point for the derivation 
of air limits. The CHEM/AAL documentation acknowledges that the use of occupational 
limits as starting points does have certain limitations since these levels are often not 
based only on health considerations but also incorporate such factors as technical 
feasibility and cost. Nevertheless, the occupational literature represented the best 
available source of information at the time. 
 
With the development of EPA's methodology to derive inhalation Reference 
Concentrations (RfCs), a consistent source of air exposure criteria became available. 
Because RfCs are toxicologically more current and are based only on toxicity 
considerations, they are more appropriate starting points for the derivation of ambient air 
guidance than are occupational limits. The following is a discussion of ORS' policy to 
incorporate inhalation RfCs into the guideline-derivation process for those compounds 
for which RfCs are available. The traditional method of deriving air limits as presented in 
the CHEM/AAL methodology document will continue to be used for those compounds 
without RfCs. 
 
Inhalation Reference Concentrations 
 
Inhalation Reference Concentrations (RfCs) represent benchmark air 
concentrations to which a receptor can be exposed chronically through inhalation and 
expect to suffer no adverse effects. The EPA defines an RfC as an estimate (with 
uncertainty spanning perhaps an order of magnitude) of a daily inhalation exposure of the 
human population (including sensitive subgroups) that is likely to be without an 
appreciable risk of deleterious effects during a lifetime. The methodology to derive 
inhalation RfCs, developed by the U.S. Environmental Protection Agency (EPA), is 
similar to EPA's methodology to derive oral Reference Doses (RfDs). The same general 
principles are used in both methodologies, but the RfC methodology is expanded to 
account for the dynamics of the respiratory system as the portal of entry, in addition to 
extrarespiratory effects. As is discussed in Interim Methods for Development of 
Inhalation Reference Concentrations (EPA, 1990), the major difference between the two 
methods is that the inhalation RfC methodology includes dosimetric adjustments to 
account for species-specific relationships of inhaled concentrations and 
deposited/delivered doses. Particles and gases are treated separately and the site of the 
observed toxic effect (respiratory and extrarespiratory) is considered in applying the 
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dosimetric adjustments. 
 
Inhalation RfCs are derived by applying a series of uncertainty factors to an effect 
level derived from a toxicological study. This toxicological level is either a No Observed 
Adverse Effect Level (NOAEL) or Lowest Observed Adverse Effect Level (LOAEL) 
which has been dosimetrically adjusted to estimate a human-equivalent concentration 
(HEC). Inhalation RfCs are defined by the equation: 
 
RfC[HEC] = NOAEL[HEC]/(UF x MF) 
 
where NOAEL[HEC] represents a human-equivalent No Observed Adverse Effect Level 
(corrected for continuous exposure), UF designates the series of uncertainty factors 
applied and MF designates a modifying factor which is applied based on professional 
judgment about the adequacy of the entire data base of the chemical. 
 
The uncertainty factors applied are generally of an order of magnitude (i.e., 10). 
They are used to account for intra- and inter- species differences, differences in exposure 
time and to extrapolate from a LOAEL to a NOAEL. Occasionally, EPA uses one 
uncertainty factor of 10 to adjust for more than one parameter. The magnitude of the 
modifying factor can range from 0-10. 
 
RfCs represent a consistently derived source of toxicity criteria for inhalation 
exposures. The basic philosophy behind the derivation of these numbers is very similar to 
the approach used by the Department of Environmental Protection (DEP) to derive 
Threshold Effects Exposure Limits (TELs) from occupational limits as described in the 
Chemical Health Effects Assessment Methodology and the Method to Derive Allowable 
Ambient Limits (CHEM/AAL) (DEP, 1990). In both cases, a starting toxicological value 
is adjusted to be made applicable to exposures experienced by the general population and 
to account for effects not accounted for by that value. Both types of criteria are developed 
to be protective for chronic, continuous exposure and are developed to account for 
adverse threshold or noncarcinogenic health effects. 
 
However, the toxicological studies used to derive inhalation RfCs are more current 
than the toxicological bases for many of the occupational limits used to derive TELs. The 
RfCs are derived using a consistent quantitative approach and are not simply established 
as consensus values by a group of experts as is the case with many occupational limits. In 
addition, RfCs consider a range of health effects and are not primarily based on irritant or 
short-term effects as many occupational exposure limits are. 
 
Incorporation of RfCs into the CHEM/AAL Process 
 
Because inhalation RfCs are inherently more comprehensive, more applicable to 
the general public and toxicologically more current than occupational limits, a decision 
was made to incorporate the consideration of inhalation RfCs, when available, into the 
CHEM/AAL process. The intent of this change is not to abandon the CHEM/AAL 
methodology but to build upon and improve it. In the same way that adequate cancer 
potency data are incorporated into the CHEM/AAL methodology when available, 
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adequate inhalation RfCs will be included in the process when available. The overall 
CHEM/AAL methodology will thus remain the same with the exception that inhalation 
RfCs will be incorporated into the process on a case-by-case basis. 
 
Compound-specific hazard scores for carcinogenicity, mutagenicity and 
developmental/reproductive toxicity will be derived using the same process described in 
CHEM/AAL, relying as much as possible on peer-reviewed secondary sources of 
information. These scores will be used, if necessary, to assign uncertainty factors in the 
derivation process. 
 
Revised hazard scores will not be developed for acute/chronic toxicity when RfCs 
are available. The scheme for deriving a hazard score for acute/chronic toxicity is 
partially based on the magnitude of the compound's occupational limit. In addition, 
acute/chronic hazard scores have never served as the basis for assigning uncertainty 
factors in the CHEM/AAL system. Thus, derivation of hazard scores for acute/chronic 
toxicity will not be conducted as part of the revised AAL-derivation process when RfCs 
are being used. An updated scheme for deriving compound-specific hazard scores based 
on indicators other than occupational limits may be developed as a separate project. This 
scheme may be incorporated in the CHEM/AAL process at a later date. However, the 
information provided by the acute/chronic hazard scores will have a qualitative function 
only in the AAL-derivation process. 
 
The basis of an individual RfC and the uncertainty factors incorporated in its 
derivation will be reviewed in the context of the available toxicity information from EPA 
and other pertinent sources. A determination will be made as to its appropriateness for 
use in setting a guideline. The assumptions used in deriving the RfC will be compared to 
the assumptions used in deriving a TEL to assure that the RfC-based number provides the 
same degree of protection to the public health as the TEL. 
 
In general, RfCs have already been corrected for continuous exposure. Thus, the 
4.2 factor used to adjust for continuous exposure in CHEM/AAL is not applicable for this 
purpose. An uncertainty factor of 10 is incorporated into the derivation of the RfC that 
already accounts for differences in sensitive individuals and children. The factors of 10 
and 1.75, respectively, which account for these parameters in the CHEM/AAL process, 
do not need to be applied. The TOX and TEUF factors are applied on a case-by-case 
basis as needed. A multi-media exposure factor to account for relative source 
contribution via air exposures is not applied in the RfC derivation methodology. Thus, 
the 20% factor used in CHEM/AAL is usually applied to the RfC, except in the case of 
water soluble gases (such as NH , H2S and HCl) since it is assumed that chronic exposure 
to these compounds would be largely via inhalation. Although each RfC will be reviewed 
on a case-by-case basis, the following general guidelines presented in Table 1 will be 
used for the application of adjustment factors and uncertainty factors to the RfC: 
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Table 1.  Guidelines for the Application of Adjustment and Uncertainty Factors for the 
Derivation of a TEL from an RfC and Comparison with Present MAOL-Based 
Methodology. 
 
MAOL as basis: 
o divide by 4.2 to adjust for continuous 
exposure 
o divide by 1.75 to account for 
differences between adults and 
children 
o divide by 10 to account for high-risk 
groups 
o divide by 10 on a case-by-case basis 
to account for inadequate toxicity data 
(TOX factor) 
 
Inhalation RfC as basis: 
o do not divide by 4.2; already accounts 
for continuous exposure 
o do not divide by 1.75; factor of 10 
applied for sensitive individuals already 
accounts for 
o do not divide by 10; factor of 10 applied 
for sensitive individuals already 
accounts for 
o divide by 10 on a case-by-case basis 
to account for inadequate toxicity data 
(TOX factor) not already accounted for 
in the RfC derivation process 
 
"ADJUSTED MAOL"' 
o divide by 1, 5 or 10 to account for 
threshold effects not accounted for in 
the MAOL (TEUF factor) 
o multiply by 20% to account for relative 
source contribution 
 
"ADJUSTED RfC" 
o divide by 1,5 or 10 to account for 
threshold effects not already accounted 
for in the RfC derivation process 
(TEUF factor) 
o multiply by 20%, if appropriate, to 
account for relative source contribution 
 
The value estimated above represents the TEL since it considers only threshold 
effects. To derive an AAL, the same approach would be used as described in the 
CHEM/AAL document. When adequate cancer potency data exist, then these data are 
used to derive a value which corresponds to a one in 1,000,000 cancer risk. If these data 
do not exist, then the approach described in CHEM/AAL for-developing a limit based on 
nonthreshold effects, the Non Threshold Effects Exposure Limit (NTEL), is used. The 
information (reflected in the hazard scores) for carcinogenicity and mutagenicity, 
together with information on the structure-activity relationship for that chemical are used 
to assign a Non Threshold Effects Uncertainty Factor (NTEUF) which is applied to the 
Adjusted RfC in this case (see above). The final AAL will continue to be determined as 
at present, being the lower of the TEL and NTEL values. When an Inhalation RfC is not 
available for a chemical, the CHEM/AAL process based on the MAOL will continue to 
be used. 
 
The attached worksheets are used to record compound-specific hazard scores, to 
evaluate the basis for the RfC and to calculate the TEL. 
